Latest / Wilmington News Today | 2 Min News | The Daily News Now!
First Daily PCSK9 Pill Approved | Wilmington News
The FDA just approved Lipfendra, Merck’s first daily pill targeting PCSK9 — a game-changer for cholesterol management. Unlike previous injectable PCSK9 inhibitors, this oral medication slashes LDL cholesterol by 56-60% when paired with statins, offering a far more convenient option for millions with stubborn high cholesterol — especially those with inherited conditions. While mild side effects like diarrhea and dizziness were common, serious issues were rare. Long-term data on heart attack, stroke, and death prevention is still pending, with results expected in 2029. This approval marks a…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.